Our regular patent and pharma update aims to keep you informed of recent developments in United Kingdom and European law relating to patents and the pharmaceutical industry.
The UPC may be open for business in 2017 despite Brexit
A look at recent UPC developments following the June 2016 referendum
How "obvious to try" are routine steps in clinical research?
Examining recent English court decisions on "obvious to try" assessments carried out in the context of clinical trials in the pharmaceutical industry
A unified standard for the requirement of plausibility across different grounds of patent invalidity
Understanding the meaning of "plausible" in English patent law by referring to the guidance provided in recent case decisions
Deploying competition law defences in patent infringement
Noting the increasingly vigilant attitude of competition law authorities to look into settlement/licensing agreements and the deployment of competition law defences in English patent trials
Click here for summary tables with key points from recent court decisions
Read the full patent and pharma update here.
Krishna KakkaiyadiAssociate (India), London
+44 20 7466 2979